← Open Payments lookup

STEVEN KIM: Open Payments

NPI 1659040574 · PEARLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,615 in 197 payments from 18 companies in 2025. Trend: 2023 $3,159 · 2024 $2,968 · 2025 $3,615

Food & beverage: $3,504Education: $111
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.17$456
Axsome Therapeutics, Inc.14$432
Teva Pharmaceuticals USA, Inc.15$365
E.R. Squibb & Sons, L.L.C.20$328
Otsuka America Pharmaceutical, Inc.17$321
ABBVIE INC.22$275
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)22$274
Supernus Pharmaceuticals, Inc.15$240
Vanda Pharmaceuticals Inc.11$223
Takeda Pharmaceuticals U.S.A., Inc.14$165

Products named: INGREZZA, Auvelity, COBENFY, VRAYLAR, CAPLYTA, Qelbree, FANAPT, REXULTI.

Industry payments across TX — which companies pay providers there.